General discussion, page-8874

I've held a position in IHL for several months, first time posting here.

I've monitored a few hot copper forums and for sure this contains some of the most intelligent and communicative commenters. It's particularly great still having some of the early investors around. Everyone looks at things a different way and tells a different story.

That coupled with my own research/thoughts, interviews with med science friends discussing their incredible medical results (I'm an accountant limited with med tech knowledge), personal experience with both CBD oil and smoking weed on a camping trip myself every now and then. The psychedelics are old news we have seen multiple studies from the 70s about the benefits of psychedelics and therapy. All saying there is a significant benefit to psychotherapy for severely depressed/anxious persons.

The above are long term upsides. Below are my short term upsides:

• The timing of the impending Nasdaq listing - in my opinion announced within the next 5 business days. The first November NASDAQ company IPO has been announced it would certainly not surprise me if we are next monitor yourself https://www.nasdaq.com/market-activity/ipos
• The build up of excitement to IPO (we have Sugar who is god level at this and Roth managing the investors)
• The IPO will be oversubscribed and i believe we will see a large re-rate up. Comparisons between us and ATAI. ATAI are big in the psychedelics but i don't believe have the CBD/Hydroxy drugs. ATAI is 2.1 billion market cap which is just over 5 times our market cap. This could happen fast in my opinion.

Combining both of these i have moved my portfolio to 90% IHL and the rest is Aldoro in case anyone wondered. I am extremely bullish on IHL at this point in time.

Good luck to all holders, please remember the above are just my opinion and do your own research, invest in your chosen risk profile.

I hope this company fulfils investors and patients dreams.

Best of luck to all holders.